Hetero
India - HyderabadBiotechnology
Focus: Hetero is a public Indian pharmaceutical company headquartered in Hyderabad with a diversified portfolio spanning APIs, generics, and biosimilars across infectious diseases, oncology, and cardiovascular markets.
Profile data last refreshed 12h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Hetero
AI assessmentNot HiringNo open roles listed right now. Follow Hetero to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
1 in 5yr
HYFTOR
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$91M Part DDeclining
Post-LOE
Flagship product generating 70% of company revenue; mature generic with expected competitive erosion post-LOE.
Help build intelligence for Hetero
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.